Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Global Neuralgia Treatment Market to reach USD 2.9 billion by 2027

Global Neuralgia Treatment Market Size study, by Treatment (Drug Based, Surgery), by End-User (Hospitals & Clinics, Ambulatory Surgery Center, Others) and Regional Forecasts 2020-2027

Product Code: HALMD_58497365
Publish Date: 14-12-2020
Page: 200

Global Neuralgia Treatment Market is valued approximately at USD 1.8 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 6% over the forecast period 2020-2027. Neuralgia is an anomalous symptom which causes intense and mostly severe pain, due to damaged or irritated nerve. Neuralgia treatment procedures are proven to be an effective treatment option, which helps to cure disorders caused by the damages nerve, including diabetes, cardiovascular diseases, and many more. Potential neuralgia treatment methods may include surgery to ease the pressure, regulate sugar level in the blood of diabetic patient, physical therapy, epidural injections to reduce pain, etc., which ultimately expand the scope of neuralgia treatment around the world. Further, the increase in the neuralgia treatment market is significantly imputed to the fact that the presence of better diagnostic criteria options and access to neuralgia treatment service is relentlessly expanding across the globe. Moreover, the rise in prevalence of diabetes and trigeminal neuralgia along with growing geriatric population around the world are the few other factors responsible for the CAGR of the market during the forecast period. According to the International Diabetic Federation (IDF), there were 463 million adults aged between 20-79 years are living with diabetes in 2019 worldwide, and this prevalence is likely to reach at almost 700 million by the year 2045. Likewise, as per the IDF Diabetes Atlas in 2019, the numbers of diabetic patients in Europe is likely to reach around 68 million by the year 2045, and the total health expenditure for the treatment of diabetes is valued at USD 214 billion. This, in turn, is expected to strengthen the demand for neuralgia treatment, accelerating the market growth all over the world. However, the high cost of the treatment coupled with the lack of skilled healthcare professionals are the few factors restraining the market growth over the forecast period of 2020-2027.

The regional analysis of the global Neuralgia Treatment market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the growing awareness among people for neuralgia treatment along with the presence of a significant number of market vendors in the region. Whereas Asia-Pacific is anticipated to exhibit the highest growth rate / CAGR over the forecast period 2020-2027. Factors such as the rise in prevalence of diabetes and neuralgia disorder followed by the growing aging population in the countries, such as China and India, would create lucrative growth prospects for the Neuralgia Treatment market across the Asia-Pacific region.

Major market player included in this report are:
GlaxoSmithKline PLC
Pfizer Inc.
Novartis AG
Biogen Inc.
Cadila Healthcare Limited
Lundbeck Pharmaceuticals LLC
Allergan Plc
Merz Pharma GmbH & Co.
Trigemina Inc.,
Abbott Laboratories

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Treatment:
Drug Based

By End-User:
Hospitals & Clinics
Ambulatory Surgery Center

By Region:
North America

Asia Pacific
South Korea
Latin America
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027

Target Audience of the Global Neuralgia Treatment Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1. Neuralgia Treatment Market, by Region, 2018-2027 (USD Billion)
1.2.2. Neuralgia Treatment Market, by Treatment, 2018-2027 (USD Billion)
1.2.3. Neuralgia Treatment Market, by End-User, 2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Neuralgia Treatment Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Neuralgia Treatment Market Dynamics
3.1. Neuralgia Treatment Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Neuralgia Treatment Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2017-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Neuralgia Treatment Market, by Treatment
5.1. Market Snapshot
5.2. Global Neuralgia Treatment Market by Treatment, Performance – Potential Analysis
5.3. Global Neuralgia Treatment Market Estimates & Forecasts by Treatment 2017-2027 (USD Billion)
5.4. Neuralgia Treatment Market, Sub Segment Analysis
5.4.1. Drug Based
5.4.2. Surgery
Chapter 6. Global Neuralgia Treatment Market, by End-User
6.1. Market Snapshot
6.2. Global Neuralgia Treatment Market by End-User – Potential Analysis
6.3. Global Neuralgia Treatment Market Estimates & Forecasts by End-User 2017-2027 (USD Billion)
6.4. Neuralgia Treatment Market, Sub Segment Analysis
6.4.1. Hospitals & Clinics
6.4.2. Ambulatory Surgery Center
6.4.3. Others
Chapter 7. Global Neuralgia Treatment Market, Regional Analysis
7.1. Neuralgia Treatment Market, Regional Market Snapshot
7.2. North America Neuralgia Treatment Market
7.2.1. U.S. Neuralgia Treatment Market Treatment breakdown estimates & forecasts, 2017-2027 End-User breakdown estimates & forecasts, 2017-2027
7.2.2. Canada Neuralgia Treatment Market
7.3. Europe Neuralgia Treatment Market Snapshot
7.3.1. U.K. Neuralgia Treatment Market
7.3.2. Germany Neuralgia Treatment Market
7.3.3. France Neuralgia Treatment Market
7.3.4. Spain Neuralgia Treatment Market
7.3.5. Italy Neuralgia Treatment Market
7.3.6. Rest of Europe Neuralgia Treatment Market
7.4. Asia-Pacific Neuralgia Treatment Market Snapshot
7.4.1. China Neuralgia Treatment Market
7.4.2. India Neuralgia Treatment Market
7.4.3. Japan Neuralgia Treatment Market
7.4.4. Australia Neuralgia Treatment Market
7.4.5. South Korea Neuralgia Treatment Market
7.4.6. Rest of Asia Pacific Neuralgia Treatment Market
7.5. Latin America Neuralgia Treatment Market Snapshot
7.5.1. Brazil Neuralgia Treatment Market
7.5.2. Mexico Neuralgia Treatment Market
7.6. Rest of The World Neuralgia Treatment Market
Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. GlaxoSmithKline PLC Key Information Overview Financial (Subject to Data Availability) Product Summary Recent Developments
8.2.2. Pfizer Inc.
8.2.3. Novartis AG
8.2.4. Biogen Inc.
8.2.5. Cadila Healthcare Limited
8.2.6. Lundbeck Pharmaceuticals LLC
8.2.7. Allergan Plc
8.2.8. Merz Pharma GmbH & Co.
8.2.9. Trigemina Inc.,
8.2.10. Abbott Laboratories
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption

The study of the market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geographies to provide a better regional outlook. In the report, country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. Our analysts contact company executives, managers, key opinion leaders, and industry experts. This enables our analyst to derive the closest possible figures without any major deviations in the actual number.

Primary Research Sources:

  • Interview conducted with raw material suppliers & manufacturers.
  • Interview conducted with manufacturers, suppliers & distributors, researchers, & representatives of regulatory bodies.
  • Interview conducted with market players, industry experts, & independent consultants.
  • Secondary Research Sources:
  • Purchased Database: D&B Hoovers, Bloomberg, Inc., Business Information Industry Association, NAICS Association.
  • Internal Database: White papers, Certified Publications, Articles by Recognized Authors and Regulatory Bodies.
  • Government Databases: Food and Agriculture Organization (FAO), European Industrial Hemp Association (EIHA), World Health Organization (WHO), Food and Drug Administration (FDA), International Telecommunication Union (ITU), United States Department of Agriculture (USDA), International organization of Motor Vehicle Manufacturers (OICA).

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com


Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now